News

Looking for entrance into medical school, Daryl Traylor decided to enroll at MSU for an online Master's degree in Pharmacology. He's now in his second year of medical school and knows MSU played a key role.

The goal of the Lansing-based Aitch Foundation fellowship is to study, and perhaps inhibit, a liver enzyme that has been shown to help cancer cells resist chemotherapy. "We want to provide patients with alternatives," she said.

The Collaborative Online International Learning Faculty Fellows Program strives to make global learning more accessible to MSU students as well as a students who are part of the Alliance for African Partnership.

Long interested in research and science, Amanda Jurgelewicz earned her Ph.D. at MSU and is continuing her work at the EPA's Center for Computational Toxicology and Exposure. "This research is important, and I’d like to continue it as long as I can," she said.

Derek Decloux wanted a deeper understanding of how drugs, especially anesthetics, impacted dental patients and MSU's online pharmacology and toxicology master's program proved to be a perfect fit for him. "It has opened opportunities for me," he said.

IPSTP retreat highlights updates and research from the past year and celebrates the service of one of its trailblazers, Dr. Richard Neubig.

For UCSD Professor Emeritus Dr. Paul Insel, receiving the 2024 Theodore M. Brody Distinguished Lecturer Award was an unexpected blast from the past.

In a long-standing department tradition, the newest Ph.D. students brought their early research to an audience of faculty and colleagues. Said Ph.D. program director Dr. Jamie Bernard: "It was an opportunity to effectively communicate science."

The Ghana native sent a cold email from a colder Scotland to Dr. James Luyendyk seeking to study PhmTox at MSU and it has proven to be an educational relationship for both of them

He has taken his MSU training to Worldwide Clinical Trials where he works with pharmaceutical companies to establish clinical trials for people afflicted with rare diseases. "The long-term goal is always to get the drug approved,” he said.